Fields of Application for Membrane Proteins

VDAC_3emn 1 M_RGB-jpgExpression of membrane proteins is no longer an issue

Today, membrane proteins remain a clinically relevant target, representing up to 60% of all pharmaceutical targets. However, classical expression techniques are limited due to several features.
Synthelis’ proprietary cell-free technology has been specifically designed to overcome these limitations, providing you with a large amount of functional membrane protein in an environment mimicking a living cell.